Coverage continues of Gov. Tina Kotek's announcement that OHSU has secured additional mifepristone, an FDA-approved drug to end early pregnancy, for the OHA stockpile, following election results.

Coverage continues of Gov. Tina Kotek's announcement that OHSU has secured additional mifepristone, an FDA-approved drug to end early pregnancy, for the OHA stockpile, following election results.

Ahmad Masri, M.D., discusses two of his studies presented during the American Heart Association Annual Scientific Sessions 2024 conference. Masri discusses with HCP Live a study detailing changing risk profiles and outcomes in trials among patients with ATTR-CM. The research team says study results provide evidence of a changing risk profile and outcomes, which is indicative of the effects disease-modifying treatments, such as tafamidis, acoramidis and vutrisiran, and diagnostic advances have had on earlier diagnosis of patients with ATTR-CM.

Ahmad Masri, M.D., discusses two of his studies presented during the American Heart Association Annual Scientific Sessions 2024 conference. Masri discusses with HCP Live data from the FOREST-HCM trial examining effects of aficamten in patients with oHCM eligible for septal reduction therapy at baseline. He says, “This is an open level study, so you can't always take everything from it and say, ‘I have the highest level of evidence [and] that this is being achieved’. However, what I would argue is day in, day out, in the clinic, this is what we use to treat patients. We use their symptoms, their LVOT gradient, how they feel, my impression or the physician's impression of what's going on, and we recommend to them surgery or no surgery.”

The state of Oregon awards Portland State University $1.8 million for two workforce development and training projects that, in partnership with the Northwest Native American Center for Excellence at OHSU, will strengthen career pathways for Native students and tribal communities in the high-demand fields of health care and technology.

BBC News covers the challenges of IVF and highlights efforts by scientists like Paula Amato, M.D., to improve the process. She talks about innovations in in vitro gametogenesis, or IVG, that may allow for the generation of sperm or egg cells from a simple tissue sample, such as a person's skin cells. "If it comes to fruition, it would be revolutionary — almost as revolutionary as IVF itself," she says.

Ken Hawkins, 77, of Grants Pass is the first Oregonian to participate in a first-of-its kind clinical trial of an experimental blood infusion that can gene-edit a person’s liver cells to improve heart function. Ahmad Masri, M.D., says, “We’re excited to be one of the few centers offering access to this clinical trial on the West Coast.”

The state of Oregon awards Portland State University $1.8 million for two workforce development and training projects that, in partnership with the Northwest Native American Center for Excellence at OHSU, will strengthen career pathways for Native students and tribal communities in the high-demand fields of health care and technology.

Ken Hawkins, 77, of Grants Pass is the first Oregonian to participate in a first-of-its kind clinical trial of an experimental blood infusion that can gene-edit a person’s liver cells to improve heart function. Ahmad Masri, M.D., says, “We’re excited to be one of the few centers offering access to this clinical trial on the West Coast.

The Daily Journal of Commerce reports construction of the 14-story inpatient addition is proceeding on Marquam Hill. OHSU says the IPA’s primary services will be surgical oncology and cellular therapy. The building is expected to open with 128 beds and enough space to hold up to 64 more in April 2026.